HRTX News and Press, Heron Therapeutics Inc. From 03/13/23

Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023 Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVI...

Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023 PR Newswire SAN DIEGO , March 10, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on i...

2023-03-08 22:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-07 14:00:39 ET The following slide deck was published by Heron Therapeutics, Inc. in conjunction with this event. For further details see: Heron Therapeutics (HRTX) presents at 2023 Cowen Conference - Slideshow

Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults PR Newswire - APONVIE, the first and only intravenous (IV) formulation of a substance P/neurokinin-1 (NK 1 ) receptor antagonist ind...

Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference PR Newswire SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Penny stocks, also known as micro-cap stocks, are low-priced stocks that trade for less than $5 per share. Despite their low prices, these stocks can be a great way to make money in the stock market. However, they are also high-risk investments that can easily lead to significant lossesToto be su...

Heron Therapeutics ( NASDAQ: HRTX ) shares rose ~10% on Wednesday morning after announcing a cooperation agreement with two of its shareholders, Rubric Capital Management LP and Velan Capital Investment Management LP. Per the terms, Heron ( HRTX ) has agreed to add Craig Colla...

Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital PR Newswire Appoints Three New Independent Directors SAN DIEGO , Feb. 22, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ: HRTX) ("Heron" or the "Company"), a...